SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-23-236920
Filing Date
2023-09-18
Accepted
2023-09-18 16:12:44
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B4 d241143d424b4.htm 424B4 2604986
2 GRAPHIC g241143g28u84.jpg GRAPHIC 169031
3 GRAPHIC g241143g37a37.jpg GRAPHIC 109097
4 GRAPHIC g241143g56z79.jpg GRAPHIC 110470
5 GRAPHIC g241143g65g74.jpg GRAPHIC 202991
6 GRAPHIC g241143g73f63.jpg GRAPHIC 86854
7 GRAPHIC g241143g75k94.jpg GRAPHIC 132323
8 GRAPHIC g241143g86c02.jpg GRAPHIC 37470
  Complete submission text file 0001193125-23-236920.txt   3770836
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-274229 | Film No.: 231261315
SIC: 2836 Biological Products, (No Diagnostic Substances)